Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -2,475 | -8,206 | N/A | -6,189 |
| Depreciation Amortization | N/A | 134 | 471 | N/A | 371 |
| Accounts receivable | N/A | 123 | 59 | N/A | -450 |
| Accounts payable and accrued liabilities | N/A | 311 | 3 | N/A | 235 |
| Other Working Capital | N/A | 514 | 704 | N/A | -64 |
| Other Operating Activity | 0 | 288 | -457 | 0 | 2,485 |
| Operating Cash Flow | $N/A | $-1,105 | $-7,426 | $N/A | $-3,612 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -521 | -139 | N/A | -39 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 11 |
| Investing Cash Flow | $N/A | $-521 | $-139 | $N/A | $-28 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 21,430 | N/A | 12,923 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -191 |
| Financing Cash Flow | $N/A | $N/A | $21,430 | $N/A | $12,732 |
| Exchange Rate Effect | N/A | -359 | 575 | N/A | 252 |
| Beginning Cash Position | N/A | 17,517 | 3,077 | N/A | 2,890 |
| End Cash Position | N/A | 15,532 | 17,517 | N/A | 12,235 |
| Net Cash Flow | $N/A | $-1,985 | $14,440 | $N/A | $9,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -1,105 | -7,426 | N/A | -3,612 |
| Capital Expenditure | N/A | -521 | -139 | N/A | -39 |
| Free Cash Flow | 0 | -1,626 | -7,565 | 0 | -3,651 |